462 related articles for article (PubMed ID: 8608131)
21. Functional changes in the regulatory subunit of the type II cyclic adenosine 3':5'-monophosphate-dependent protein kinase isozyme during normal and neoplastic lung development.
Butley MS; Beer DG; Malkinson AM
Cancer Res; 1984 Jun; 44(6):2689-97. PubMed ID: 6327022
[TBL] [Abstract][Full Text] [Related]
22. Endogenous tryptophan residues of cAPK regulatory subunit type IIbeta reveal local variations in environments and dynamics.
Zawadzki KM; Pan CP; Barkley MD; Johnson D; Taylor SS
Proteins; 2003 Jun; 51(4):552-61. PubMed ID: 12784214
[TBL] [Abstract][Full Text] [Related]
23. Consequences of cAMP-binding site mutations on the structural stability of the type I regulatory subunit of cAMP-dependent protein kinase.
Cànaves JM; Leon DA; Taylor SS
Biochemistry; 2000 Dec; 39(49):15022-31. PubMed ID: 11106480
[TBL] [Abstract][Full Text] [Related]
24. PKA from Mucor circinelloides: model to study the role of linker I in the interaction between R and C subunits.
Ocampo J; Moreno S; Rossi S
Biochem Biophys Res Commun; 2007 Oct; 362(3):721-6. PubMed ID: 17761146
[TBL] [Abstract][Full Text] [Related]
25. Dissection of the nucleotide and metal-phosphate binding sites in cAMP-dependent protein kinase.
Herberg FW; Doyle ML; Cox S; Taylor SS
Biochemistry; 1999 May; 38(19):6352-60. PubMed ID: 10320366
[TBL] [Abstract][Full Text] [Related]
26. Analysis of A-kinase anchoring protein (AKAP) interaction with protein kinase A (PKA) regulatory subunits: PKA isoform specificity in AKAP binding.
Herberg FW; Maleszka A; Eide T; Vossebein L; Tasken K
J Mol Biol; 2000 Apr; 298(2):329-39. PubMed ID: 10764601
[TBL] [Abstract][Full Text] [Related]
27. Novel, isotype-specific sensors for protein kinase A subunit interaction based on bioluminescence resonance energy transfer (BRET).
Prinz A; Diskar M; Erlbruch A; Herberg FW
Cell Signal; 2006 Oct; 18(10):1616-25. PubMed ID: 16524697
[TBL] [Abstract][Full Text] [Related]
28. Ala335 is essential for high-affinity cAMP-binding of both sites A and B of cAMP-dependent protein kinase type I.
Zorn M; Fladmark KE; Ogreid D; Jastorff B; Døskeland SO; Dostmann WR
FEBS Lett; 1995 Apr; 362(3):291-4. PubMed ID: 7729515
[TBL] [Abstract][Full Text] [Related]
29. Role of MgATP in the activation and reassociation of cAMP-dependent protein kinase I: consequences of replacing the essential arginine in cAMP binding site A.
Neitzel JJ; Dostmann WR; Taylor SS
Biochemistry; 1991 Jan; 30(3):733-9. PubMed ID: 1846304
[TBL] [Abstract][Full Text] [Related]
30. Dissecting interdomain communication within cAPK regulatory subunit type IIbeta using enhanced amide hydrogen/deuterium exchange mass spectrometry (DXMS).
Zawadzki KM; Hamuro Y; Kim JS; Garrod S; Stranz DD; Taylor SS; Woods VL
Protein Sci; 2003 Sep; 12(9):1980-90. PubMed ID: 12930997
[TBL] [Abstract][Full Text] [Related]
31. Dissecting the cooperative reassociation of the regulatory and catalytic subunits of cAMP-dependent protein kinase. Role of Trp-196 in the catalytic subunit.
Gibson RM; Taylor SS
J Biol Chem; 1997 Dec; 272(51):31998-2005. PubMed ID: 9405392
[TBL] [Abstract][Full Text] [Related]
32. Mapping the functional domains of human recombinant phosphodiesterase 4A: structural requirements for catalytic activity and rolipram binding.
Jacobitz S; McLaughlin MM; Livi GP; Burman M; Torphy TJ
Mol Pharmacol; 1996 Oct; 50(4):891-9. PubMed ID: 8863835
[TBL] [Abstract][Full Text] [Related]
33. Dissecting the domain structure of the regulatory subunit of cAMP-dependent protein kinase I and elucidating the role of MgATP.
Ringheim GE; Taylor SS
J Biol Chem; 1990 Mar; 265(9):4800-8. PubMed ID: 2156855
[TBL] [Abstract][Full Text] [Related]
34. Kinetic analyses of mutations in the glycine-rich loop of cAMP-dependent protein kinase.
Grant BD; Hemmer W; Tsigelny I; Adams JA; Taylor SS
Biochemistry; 1998 May; 37(21):7708-15. PubMed ID: 9601030
[TBL] [Abstract][Full Text] [Related]
35. A Myxococcus xanthus CbpB containing two cAMP-binding domains is involved in temperature and osmotic tolerances.
Kimura Y; Nakato H; Ishibashi K; Kobayashi S
FEMS Microbiol Lett; 2005 Mar; 244(1):75-83. PubMed ID: 15727824
[TBL] [Abstract][Full Text] [Related]
36. Isoleucine 368 is involved in low-affinity binding of N6-modified cAMP analogues to site B of the regulatory subunit of cAMP-dependent protein kinase I.
Huq I; Dostmann WR; Ogreid D
Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):337-43. PubMed ID: 8645227
[TBL] [Abstract][Full Text] [Related]
37. A constitutively active holoenzyme form of the cAMP-dependent protein kinase.
Wang YH; Scott JD; McKnight GS; Krebs EG
Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2446-50. PubMed ID: 1848703
[TBL] [Abstract][Full Text] [Related]
38. Phosphorylation of regulatory subunit of type I cyclic AMP-dependent protein kinase: biphasic effects of cyclic AMP in intact S49 mouse lymphoma cells.
Russell JL; Steinberg RA
J Cell Physiol; 1987 Feb; 130(2):207-13. PubMed ID: 3029147
[TBL] [Abstract][Full Text] [Related]
39. A point mutation abolishes binding of cAMP to site A in the regulatory subunit of cAMP-dependent protein kinase.
Bubis J; Neitzel JJ; Saraswat LD; Taylor SS
J Biol Chem; 1988 Jul; 263(20):9668-73. PubMed ID: 2898473
[TBL] [Abstract][Full Text] [Related]
40. Contribution of the carboxyl-terminal regional of the cAMP-dependent protein kinase type I alpha regulatory subunit to cyclic nucleotide interactions.
Kapphahn MA; Shabb JB
Arch Biochem Biophys; 1997 Dec; 348(2):347-56. PubMed ID: 9434747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
